Fund Evaluator:
Fidelity MSCI North American SbsetIdxETF (FINA)
Follow This Fund
Equity
Global Asset Class
U.S. Equity
Fund Group
Large Blend
Category
$0.000
NAV (as of )
$0.00
Minimum Initial
0.09% A
Expense Ratio
$1,196 Mil
Assets
Open
Status
na
12b-1 Fee
na
TTM Yield
0.00%
Max Load
na
Portfolio Turnover
Best Performing in Large Blend Over the Last Year
| 49.8% | PRIMECAP Odyssey Growth (POGRX) |
| 48.6% | Vanguard PRIMECAP Core Inv (VPCCX) |
| 45.8% | Vanguard PRIMECAP Adm (VPMAX) |
| 45.7% | Vanguard PRIMECAP Inv (VPMCX) |
| 42.3% | Midas Special Opportunities (MISEX) |
Data as of 7/31/2026
na
1-Mo Return
na
3-Mo Return
na
YTD Return
na
1-Yr Return
na
3-Yr Return
na
5-Yr Return
na
Category Risk Index
na
Total Risk Index
Fund Details
Fund Family
Fidelity Investments
Inception Date
7/7/2026
Share Class Type
Equity Investment Style
Large-Cap
Blend
Bond Investment Style
na
Socially Responsible Fund
No
Index Fund
Yes
Benchmark Index
MSCI Glbl 500 Slct - NrthAmrcSbst TR USD: 100%
Additional Fund Details
Fidelity MSCI North American SbsetIdxETF Overview
FINA Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| FINA Return (NAV) | na | na | na | na | na | na |
| FINA Grade | na | na | na | na | na | na |
| +/- Category | na | na | na | na | na | na |
| Large Blend Avg | 0.4% | 4.1% | 17.5% | 17.3% | 11.1% | 13.7% |
| FINA Tax Cost Ratio | na | na | na | na | na | na |
FINA Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| FINA Return (NAV) | na | na | na | na | na | na | na | na | na | na | na |
| FINA Grade | na | na | na | na | na | na | na | na | na | na | na |
| +/- Category | na | na | na | na | na | na | na | na | na | na | na |
| Large Blend Avg | 9.3% | 15.8% | 22.1% | 23.7% | -17.3% | 26.5% | 17.5% | 29.8% | -5.9% | 21.3% | 10.2% |
| Risk Measures | |
| Standard Deviation: | na |
| Total Risk Index: | na |
| Category Risk Index: | na |
| Category Risk Grade: | |
| Beta: | na |
| R-Squared: | na |
| Leveraged Fund: | No |
| Inverse Fund: | No |
| Portfolio Characteristics | |
| Equity Investment Style: | Large-Cap Blend |
| Bond Investment Style: | na |
| Yield: | -- |
| Dividend Distribution: | Quarterly |
| Cap Gains Distribution: | Annually |
| Total Assets: | $1196 Mil |
| Fund Total Assets: | $1,197 Mil |
| Share Class Type: | |
| Portfolio Turnover: | na |
Management Team
| Number of Managers: 5 | |||
| Longest Tenure: 0.1 years | |||
| Average Tenure: 0.1 years | |||
| Managers (Year): Bottari Louis (2026), Gupta Payal (2026), Matthew Peter (2026), Sohrabi Navid (2026), Regan Robert (2026) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 280 |
| % in Top 10 Holdings: | 35.0% |
| Fund is Non-Diversified: | No |
| % in Foreign Issues: | 5.1% |
Portfolio Allocation |
|
| Domestic Stock: | 94.9% |
| Foreign Stock: | 5.1% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | -0.1% |
Purchase Information
| Fund Family: | Fidelity Investments |
| Phone Number: | 202-371-8300 |
| Website: | www.institutional.fidelity.com |
| Status: | Open |
| Inception Date: | July 7, 2026 |
| Min. Initial Purchase: | $ 0 |
| Min. Initial IRA Purchase: | $ 0 |
| True No-Load: | Yes |
| Front Load Maximum: | 0.00% |
| Deferred Charge Maximum: | 0.00% |
| Redemption Charge Maximum: | 0.00% |
| 12b-1 Fee: | na |
Expenses and Fees | |
| Expense Ratio (%): | 0.09% ( Rating : Low ) |
| Category Average Expense Ratio (%): | 0.81% |
| Share Class: | Fidelity MSCI North American SbsetIdxETF |
| Min. Subsequent Purchase: | $ 0 |
| Min. Subsequent IRA Purchase: | $ 0 |
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.